San Francisco, USA-based Chai Discovery, the AI company building a computer-aided design suite for molecules, has announced a ...

Europe is in danger of falling behind in the development of innovative medicines, according to Dutch pharma trade group VIG ...

Swiss biotech startup FluoSphera has raised 1.23 million euros ($1.34 million) to expand commercial activity and advance its ...

US radiopharma newcomer Aktis Oncology (Nasdaq: AKTS) raised about $318 million after pricing an upsized initial public ...

Royalty Pharma and the US affiliate of Israel’s Teva Pharmaceutical Industries have announced a funding agreement of up to ...

US pharma giant Pfizer on Saturday announced positive results from Cohort 3, a separate randomized cohort of the pivotal ...

US biotech start-up Aurora Therapeutics has launched with $16 million in seed funding from Menlo Ventures, aiming to turn one ...

Swiss pharma trade body Interpharma has warned that Switzerland’s position as a global pharmaceutical hub is under strain ...

A clinical-stage biotechnology company headquartered in Palo Alto, California. The company is focused on respiratory medicine ...

A privately held biotechnology company based in the Boston, Massachusetts area. It operates as an enabling platform business ...

A clinical-stage biotechnology company headquartered in Schlieren (Zurich), Switzerland. The company develops locally acting small-molecule therapies aimed at restoring microcirculation in diseases ...

Pharmaceutical Compliance Congress (PCC) is a specialist conference for life sciences compliance and legal leaders, focused on the enforcement landscape and the practical realities of running ...